Application of new homologous in vitro bioassays for human lactogens to assess the actual bioactivity of human prolactin isoforms in hyperprolactinaemic patients

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 146-153

  Leaños Miranda, Alfredo ^a,d   Cárdenas Mondragón, Guadalupe ^a   Rivera Leaños, Roxana ^a   Ulloa Aguirre, Alfredo ^a   Goffin, Vincent ^b,c  

^a Hospital Luis Castelazo Ayala   (Mexico)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c INSERM   (France)

^d Research Unit in Reproductive Medicine   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

ISOPROTEIN; PROLACTIN;

ADULT; ANIMAL CELL; ARTICLE; BIOASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; HYPERPROLACTINEMIA; IMMUNORADIOMETRIC ASSAY; IMMUNOREACTIVITY; IN VITRO STUDY; MALE; MEDICAL RESEARCH; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROLACTINOMA; SEQUENCE HOMOLOGY; SERUM; SYMPTOMATOLOGY;

EID: 33746081742     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02548.x     Document Type: Article

References (30)

1. Bole-Feysot, C., Goffin, V., Edery, M., Binart, N. & Kelly, P.A. (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocrine Reviews, 19, 225-268.
2. Kelly, P.A., Djiane, J., Postel-Vinay, M.C. & Edery, M. (1991) The prolactin/growth hormone receptor family. Endocrine Reviews, 12, 235-251.
3. Goffin, V., Shiverick, K.T., Kelly, P.A. & Martial, J.A. (1996) Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen, and related proteins in mammals. Endocrine Reviews, 17, 385-410.
4. Fraser, I.S. & Lun, Z.G. (1990) Polymers of prolactin and their clinical significance. Obstetetrical and Gynecology Survey, 45, 515-520.
5. Sinha, Y.N. (1995) Structural variants of prolactin: occurrence and physiological significance. Endocrine Reviews, 16, 354-364.
6. Farkouh, N.H., Packer, M.G. & Frantz, A.G. (1979) Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 47, 1026-1032.
7. Fraser, I.S., Lun, Z.G., Zhou, J.P., Herington, A.C., McCarron, G., Caterson, I., Tan, K. & Markham, R. (1989) Detailed assessment of big-big prolactin in women with hyperprolactinemia and normal ovarian function. Journal of Clinical Endocrinology and Metabolism, 69, 585-592.
8. Leaños-Miranda, A., Chávez-Rueda, K.A. & Blanco-Favela, F. (2001) Biologic activity and plasma clearance of prolactin-IgG complex in patients with systemic lupus erythematosus. Arthritis and Rheumatism, 44, 866-875.
9. Tanaka, T., Shiu, R.P.C., Gout, P.W., Beer, C.T., Noble, R.L. & Friesen, H.G. (1980) A new sensitive and specific bioassay for lactogenic hormones: measurement of prolactin and growth hormone in human serum. Journal of Clinical Endocrinology and Metabolism, 51, 1058-1063.
10. Bernichtein, S., Jeay, S., Vaudry, R., Kelly, P.A. & Goffin, V. (2003) New homologous bioassays for human lactogens show that agonism or antagonism of various analogs is a function of assay sensitivity. Endocrine, 20, 177-190.
11. Ali, S., Pellegrini, I. & Kelly, P.A. (1991) A prolactin-dependent immune cell line (Nb2) expresses a mutant form of prolactin receptor. Journal of Biological Chemistry, 266, 20110-20117.
12. Ali, S., Edery, M., Pellegrini, I., Lesueur, L., Paly, J., Djiane, J. & Kelly, P.A. (1992) The Nb2 form of prolactin receptor is able to activate a milk protein gene promoter. Molecular Endocrinology, 6, 1242-1248.
13. Shirota, M., Banville, D., Ali, S., Jolicoeur, C., Boutin, J.M., Edery, M., Djiane, J. & Kelly, P.A. (1990) Expression of two forms of prolactin receptor in rat ovary and liver. Molecular Endocrinology, 4, 1136-1143.
14. Goffin, V., Kinet, S., Ferrag, F., Binart, N., Martial, J.A. & Kelly, P.A. (1996) Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay. The Journal of Biological Chemistry, 271, 16573-16579.
15. Wakao, H., Gouilleux, F. & Groner, B. (1994) Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response. EMBO Journal, 13, 2182-2191.
16. Bernichtein, S., Jomain, J.B., Kelly, P.A. & Goffin, V. (2003) The N-terminus of human prolactin modulates its biological properties. Molecular and Cellular Endocrinology, 208, 11-21.
17. Pascoe-Lira, D., Duran-Reyes, G., Contreras-Hernández, I., Manuel-Apolinar, L., Blanco-Favela, F. & Leaños-Miranda, A. (2001) Frequency of macroprolactinemia due to autoantibodies against prolactin in pregnant women. Journal of Clinical Endocrinology and Metabolism, 86, 924-929.
18. Leaños-Miranda, A., Pascoe-Lira, D., Chávez-Rueda, K. & Blanco-Favela, F. (2001) Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus. Journal of Clinical Endocrinology and Metabolism, 86, 2619-2624.
19. Leaños-Miranda, A., Pascoe-Lira, D., Chávez-Rueda, K.A. & Blanco-Favela, F. (2001) Detection of macroprolactinemia with polyethylene glycol precipitation test in systemic lupus erythematosus patients with hyperprolactinemia. Lupus, 10, 340-345.
20. Leanõs-Miranda, A., Pascoe-Lira, D. & Blanco-Favela, F. (1998) Prolactin and systemic lupus erythematosus. British Journal of Rheumatology, 37, 1029-1030.
21. Leaños-Miranda, A., Pascoe, D., Fraga, A. & Blanco, F. (1998) Antiprolactin autoantibodies in systemic lupus erythematosus patients with associated hyperprolactinemia. Lupus, 7, 398-403.
22. Leaños-Miranda, A., Pascoe-Lira, D., Chávez-Rueda, K.A. & Blanco-Favela, F. (2001) Antiprolactin autoantibodies in systemic lupus erythematosus: frequency and correlation with prolactinemia and disease activity. Journal of Rheumatology, 28, 1546-1553.
23. Leaños-Miranda, A. & Contreras-Hernández, I. (2002) Anti-prolactin autoantibodies are associated with hyperprolactinemic status in men infected with human immunodeficiency virus. Endocrine, 19, 139-146.
24. Southern, P.J. & Berg, P. (1982) Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. Journal of Molecular and Applied Gentics, 1, 327-341.
25. Wittaker, P.G., Wilcox, T. & Lind, T. (1981) Maintained fertility in a patient with hyperprolactinemia due to big, big prolactin. Journal of Clinical Endocrinology and Metabolism, 53, 863-866.
26. Jackson, R.D., Wortsman, J. & Malarkey, W.B. (1985) Characterization of a large molecular weight prolactin in women with idiopathic hyperprolactinemia and normal menses. Journal of Clinical Endocrinology and Metabolism, 61, 258-264.
27. Hattori, N. (1996) The frequency of macroprolactinemia in pregnant women and the heterogeneity of its etiologies. Journal of Clinical Endocrinology and Metabolism, 81, 586-590.
28. Hattori, N., Ikekubo, K., Ishihara, T., Moridera, K., Hino, M. & Kurahachi, H. (1994) Effects of anti-prolactin autoantibodies on serum prolactin measurements. European Journal of Endocrinology, 130, 434-437.
29. Hattori, N. & Inagaki, C. (1997) Anti-prolactin (PRL) autoantibodies cause asymptomatic hyperprolactinemia: bioassay and clearance studies of PRL-immunoglobulin G complex. Journal of Clinical Endocrinology and Metabolism, 82, 3107-3311.
30. Glezer, A., Soares, C.R., Vieira, J.G., Giannella-Neto, D., Ribela, M.T., Goffin, V. & Bronstein, M.D. (2006) Human macroprolactin displays low biological activity via its homologous receptor in a new sensitive bioassay. Journal of Clinical Endocrinology and Metabolism, 91, 1048-1055.